Other neglected products

Building on the successful revamping of its first molecule, Provepharm is able to take up the challenge of redeveloping other neglected pharmaceutical compounds, from the inceptive chemical synthesis to the definition of final critical quality attributes of a compliant active substance and drug.

Being close to the Industry, the Regulators and the Society and thinking “outside the box”, the company has already some other molecules at early stage of re-development for their possible unsuspected properties.

At a time where R&D expenses are soaring and the need for new drugs is increasing because of ageing population, Provepharm’s flexible and agile quality by design project management capabilities may be a strategic tool to pharmaceutical players needing to demonstrate increased health and economic value and looking for improved quality and shortened time to market.